Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency in drug candidates. Commonly employed in the development of treatments for solid tumors and hematological malignancies. Also utilized in structure-activity relationship (SAR) studies to optimize metabolic stability and bioavailability of lead compounds.